GAMMA Investing’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
HWAM
VCM
ATC
FFO
EP
TWD
TCM
GAMMA Investing's FLGT Position: Q3 2026 in Review
GAMMA Investing increased its Fulgent Genetics (FLGT) stake by 41% in Q3 2026, buying an estimated $4.98K and bringing the position to 851 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2984.
GAMMA Investing first reported a position in FLGT in Q4 2023 and has held it in 12 quarters since. The position peaked at $121K in Q4 2025. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- GAMMA Investing held 851 shares of Fulgent Genetics worth $18.7K as of Q3 2026.
- GAMMA Investing bought 248 Fulgent Genetics shares in Q3 2026, an estimated $4.98K.
- Fulgent Genetics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2984 holding.
- GAMMA Investing first reported a position in Fulgent Genetics in Q4 2023 and has held it in 12 quarters since.
- GAMMA Investing's Fulgent Genetics position peaked at $121K in Q4 2025.
- 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.